Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Capital Work in Progress

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Capital Work in Progress ₹342 Cr₹151 Cr₹238 Cr₹177 Cr₹181 Cr

What is the latest Capital Work in Progress ratio of GLAND PHARMA ?

The latest Capital Work in Progress ratio of GLAND PHARMA is ₹342 Cr based on Mar2026 Consolidated results.
Year Capital Work in Progress
Mar2026₹342 Cr
Mar2025₹151 Cr
Mar2024₹238 Cr
Mar2023₹177 Cr
Mar2022₹181 Cr

How is Capital Work in Progress of GLAND PHARMA Trending?

Years Capital Work in Progress % Change
Mar2026 ₹342 Cr
127.27
Mar2025 ₹151 Cr
-36.71
Mar2024 ₹238 Cr
34.23
Mar2023 ₹177 Cr
-1.95
Mar2022 ₹181 Cr -

Compare Capital Work in Progress of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹42,583.2 Cr 6.2% 4.8% 24.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹470,270.0 Cr -1.4% 2.4% 17.1% Stock Analytics
DIVIS LABORATORIES ₹222,224.0 Cr 12.2% 23.1% 21.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,325.0 Cr 2.4% 5.3% 41.7% Stock Analytics
CIPLA ₹117,139.0 Cr 1.7% 0.7% -3.8% Stock Analytics
DR REDDYS LABORATORIES ₹96,876.6 Cr 3% -14.9% -10.2% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

6.2%

4.8%

24.3%

SENSEX

2.2%

0.9%

-3.7%


You may also like the below Video Courses